Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Carboplatin, and Gemcitabine vs Gemcitabine and Vinorelbine in Advanced NSCLC
NCT00193362Phase 3Completed
- Sponsor
- SCRI Development Innovations
- Start
- Jun 2004
- Primary completion
- Jun 2005
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 3 trial of paclitaxel, carboplatin, gemcitabine, vinorelbine in non-small cell lung cancer (NSCLC), sponsored by SCRI Development Innovations. Started Jun 2004; status: completed.
02
Drugs
paclitaxelcarboplatingemcitabinevinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00193362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193362.